WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013057322) (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/057322    International Application No.:    PCT/EP2012/070900
Publication Date: 25.04.2013 International Filing Date: 22.10.2012
IPC:
C07D 213/74 (2006.01), C07C 211/35 (2006.01), A61K 31/135 (2006.01), A61P 35/00 (2006.01), A61P 31/12 (2006.01), A61P 25/00 (2006.01)
Applicants: ORYZON GENOMICS, S.A. [ES/ES]; C/Sant Ferran, 74 E-08940 Cornellà de Llobregat (ES)
Inventors: ORTEGA MUÑOZ, Alberto; (ES).
FYFE, Matthew Colin Thor; (ES).
MARTINELL PEDEMONTE, Marc; (ES).
ESTIARTE MARTÍNEZ, María de los Ángeles; (ES).
VALLS VIDAL, Nuria; (ES).
KURZ, Guido; (ES).
CASTRO PALOMINO LARIA, Julio Cesar; (ES)
Agent: VOSSIUS & PARTNER; Siebertstraße 4 81675 München (DE)
Priority Data:
11382324.9 20.10.2011 EP
11382329.8 27.10.2011 EP
61/558,370 10.11.2011 US
61/558,369 10.11.2011 US
Title (EN) (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS
(FR) COMPOSÉS D'(HÉTÉRO)ARYL-CYCLOPROPYLAMINE À TITRE D'INHIBITEURS DE LSD1
Abstract: front page image
(EN)The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.
(FR)Cette invention concerne des composés d'(hétéro)aryl-cyclopropylamine, comprenant en particulier les composés de formule (I) ci-décrits et ci-définis, et leur utilisation en thérapie, y compris, par ex., dans le traitement ou la prévention du cancer, d'une maladie ou affection neurologique, ou d'une infection virale.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)